- Home
- ARQT vs DGNX Comparison
ARQT vs DGNX Comparison
Compare ARQT & DGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- DGNX
- Stock Information
- Founded
- ARQT 2016
- DGNX 2018
- Country
- ARQT United States
- DGNX Hong Kong
- Employees
- ARQT 342
- DGNX N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- DGNX
- Sector
- ARQT Health Care
- DGNX
- Exchange
- ARQT Nasdaq
- DGNX NYSE
- Market Cap
- ARQT 2.0B
- DGNX 1.2B
- IPO Year
- ARQT 2020
- DGNX 2025
- Fundamental
- Price
- ARQT $16.87
- DGNX $96.99
- Analyst Decision
- ARQT Strong Buy
- DGNX
- Analyst Count
- ARQT 6
- DGNX 0
- Target Price
- ARQT $18.80
- DGNX N/A
- AVG Volume (30 Days)
- ARQT 2.7M
- DGNX 78.6K
- Earning Date
- ARQT 05-13-2025
- DGNX 01-01-0001
- Dividend Yield
- ARQT N/A
- DGNX N/A
- EPS Growth
- ARQT N/A
- DGNX N/A
- EPS
- ARQT N/A
- DGNX N/A
- Revenue
- ARQT $196,542,000.00
- DGNX $1,177,066.00
- Revenue This Year
- ARQT $56.60
- DGNX N/A
- Revenue Next Year
- ARQT $43.62
- DGNX N/A
- P/E Ratio
- ARQT N/A
- DGNX N/A
- Revenue Growth
- ARQT 229.74
- DGNX N/A
- 52 Week Low
- ARQT $6.99
- DGNX $3.60
- 52 Week High
- ARQT $17.75
- DGNX $141.87
- Technical
- Relative Strength Index (RSI)
- ARQT 67.97
- DGNX N/A
- Support Level
- ARQT $16.27
- DGNX N/A
- Resistance Level
- ARQT $17.50
- DGNX N/A
- Average True Range (ATR)
- ARQT 1.09
- DGNX 0.00
- MACD
- ARQT 0.25
- DGNX 0.00
- Stochastic Oscillator
- ARQT 94.23
- DGNX 0.00
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About DGNX DIGINEX LIMITED
Diginex Ltd is an investment holding company. It engaged in providing Environmental, Social, and Governance (ESG) reporting solution services, advisory services, and developing customization solutions.